HPM Partners LLC lifted its stake in Davita Inc (NYSE:DVA) by 5.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 26,075 shares of the company’s stock after buying an additional 1,364 shares during the period. HPM Partners LLC’s holdings in Davita were worth $1,884,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Rhumbline Advisers lifted its stake in shares of Davita by 4.4% in the third quarter. Rhumbline Advisers now owns 321,155 shares of the company’s stock valued at $19,073,000 after buying an additional 13,471 shares during the period. Meag Munich Ergo Kapitalanlagegesellschaft MBH raised its position in Davita by 1,987.3% in the third quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH now owns 41,746 shares of the company’s stock worth $2,448,000 after purchasing an additional 39,746 shares in the last quarter. Schroder Investment Management Group raised its position in Davita by 769.0% in the third quarter. Schroder Investment Management Group now owns 434,191 shares of the company’s stock worth $25,387,000 after purchasing an additional 384,224 shares in the last quarter. California Public Employees Retirement System raised its position in Davita by 4.4% in the fourth quarter. California Public Employees Retirement System now owns 511,756 shares of the company’s stock worth $36,974,000 after purchasing an additional 21,624 shares in the last quarter. Finally, Oakbrook Investments LLC acquired a new position in Davita in the fourth quarter worth about $415,000. Institutional investors and hedge funds own 85.83% of the company’s stock.
Several research firms recently issued reports on DVA. SunTrust Banks set a $75.00 price target on shares of Davita and gave the stock a “hold” rating in a research report on Thursday, December 21st. Bank of America reissued a “buy” rating and issued a $92.00 price target (up previously from $85.00) on shares of Davita in a research report on Thursday, January 11th. KeyCorp reissued a “hold” rating on shares of Davita in a research report on Monday, November 13th. Robert W. Baird set a $97.00 price target on shares of Davita and gave the stock a “buy” rating in a research report on Tuesday, February 13th. Finally, Zacks Investment Research lowered shares of Davita from a “buy” rating to a “hold” rating in a research report on Tuesday, February 13th. Two research analysts have rated the stock with a sell rating, five have issued a hold rating, four have assigned a buy rating and two have assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $79.30.
Davita (NYSE:DVA) last posted its quarterly earnings data on Tuesday, February 13th. The company reported $0.92 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.94 by ($0.02). The firm had revenue of $2.78 billion for the quarter, compared to analyst estimates of $3.90 billion. Davita had a return on equity of 12.86% and a net margin of 4.65%. During the same period in the previous year, the business posted $0.98 EPS. equities research analysts forecast that Davita Inc will post 4.15 EPS for the current year.
In other news, insider James K. Hilger sold 3,572 shares of the firm’s stock in a transaction that occurred on Tuesday, January 16th. The shares were sold at an average price of $78.95, for a total transaction of $282,009.40. Following the completion of the sale, the insider now owns 33,649 shares of the company’s stock, valued at $2,656,588.55. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 2.00% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This article was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this article on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this article can be accessed at https://www.tickerreport.com/banking-finance/3257662/hpm-partners-llc-grows-position-in-davita-inc-dva.html.
Davita Company Profile
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davita Inc (NYSE:DVA).
Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.